Corbus Pharmaceuticals Holdings Inc’s filing revealed that its Director Jenkins John Kenneth unloaded Company’s shares for reported $20465.0 on May 30 ’25. In the deal valued at $7.35 per share,2,783 shares were sold. As a result of this transaction, Jenkins John Kenneth now holds 33 shares worth roughly $236.28.
Then, Altmeyer Anne sold 1,392 shares, generating $10,096 in total proceeds. Upon selling the shares at $7.25, the Director now owns 1,391 shares.
Before that, Smethurst Dominic sold 6,393 shares. Corbus Pharmaceuticals Holdings Inc shares valued at $43,330 were divested by the Chief Medical Officer at a price of $6.78 per share. As a result of the transaction, Smethurst Dominic now holds 70,807 shares, worth roughly $0.51 million.
William Blair initiated its Corbus Pharmaceuticals Holdings Inc [CRBP] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in early December with a ‘”an Overweight”‘ rating. Wedbush began covering CRBP with “an Outperform” recommendation on July 30, 2024.
Price Performance Review of CRBP
On Tuesday, Corbus Pharmaceuticals Holdings Inc [NASDAQ:CRBP] saw its stock jump 3.77% to $7.16. Over the last five days, the stock has lost -10.05%. Corbus Pharmaceuticals Holdings Inc shares have fallen nearly -83.68% since the year began. Nevertheless, the stocks have fallen -39.32% over the past one year. While a 52-week high of $61.90 was reached on 01/16/25, a 52-week low of $4.64 was recorded on 04/07/25.
Levels Of Support And Resistance For CRBP Stock
The 24-hour chart illustrates a support level at 6.86, which if violated will result in even more drops to 6.56. On the upside, there is a resistance level at 7.32. A further resistance level may holdings at 7.48.
How much short interest is there in Corbus Pharmaceuticals Holdings Inc?
A steep rise in short interest was recorded in Corbus Pharmaceuticals Holdings Inc stocks on 2025-06-13, dropping by 17285.0 shares to a total of 1.87 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 1.89 million shares. There was a decline of -0.92%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on June 26, 2024 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $85 price target.
